Objective: To compare expression of messenger RNA (mRNA) coding for the cortisol regenerating enzyme 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1), and the adipocytokines leptin and resistin in paired biopsies of subcutaneous adipose tissue (SC) and omental adipose tissue (OM) from children. Design: Paired biopsies (SC and OM) were obtained from 54 children (age 0.17-16 years, body mass index (BMI) 12.5-28.3 kg/m 2 , BMI standard deviation score (SDS) À2.5-4.5) and 16 adults (age 27-79 years, BMI 19-46 kg/m 2 ) undergoing open abdominal surgery. mRNA levels of 11b-HSD1, leptin and resistin were measured using quantitative real-time polymerase chain reaction (PCR). Results: 11b-HSD1 mRNA level was higher in OM than in SC (Po0.05), whereas leptin mRNA was higher in SC than in OM (Po0.001). There was no difference in the resistin mRNA level between SC and OM. These results were consistent in children and adults. In children, 11b-HSD1 mRNA in SC was positively associated with BMI SDS (Po0.05), whereas in OM it was positively associated with age (Po0.05). The association between 11b-HSD1 expression and age remained significant after adjustment for BMI SDS and gender. Leptin mRNA was positively associated with BMI SDS (SC: Po0.001, OM: Po0.001) but not with age in children. In multiple regression analyses, including anthropometric variables and age, BMI SDS was independently associated with mRNA levels of 11b-HSD1 (Po0.05) and leptin (Po0.001) in SC. When normal weight and overweight children were analyzed separately, 11b-HSD1 mRNA levels were positively associated with leptin in OM in the overweight group (Po0.05). Conclusion: There are depot-specific differences in mRNA levels of 11b-HSD1 and leptin in children and adults. The positive association of 11b-HSD1 mRNA in OM with age may reflect a causal role in visceral fat accumulation during growth. Increasing 11b-HSD1 and leptin mRNA in SC with increasing BMI SDS could suggest that the risk of metabolic consequences of obesity may be established early in life.
Introduction
The prevalence of overweight and obesity is becoming a major global public health concern not only in adults, but also in children. 1 Seventy to 80% of obese adolescents will remain obese as adults and it has been estimated that 30% of obese adults became obese during childhood. [2] [3] [4] Overweight and obesity during childhood and adolescence is significantly associated with insulin resistance, type 2 diabetes, dyslipidemia and elevated blood pressure in young adults. 5, 6 Particularly, central (visceral) obesity is associated with this cluster of metabolic/vascular dysfunctions and is clearly linked to an increased risk of cardiovascular disease and premature death. 7, 8 The detailed molecular basis for these associations is subject to intense research, and several recent reports suggest that specific adipose tissue-derived factors can be important mediators of obesity-related metabolic and vascular complications. [9] [10] [11] Glucocorticoids regulate adipose tissue differentiation, cellular lipid accumulation and fat distribution. Excess glucocorticoid activity as in Cushing's syndrome results in central obesity with insulin resistance, type 2 diabetes, dyslipidemia and hypertension.
12 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) is a key enzyme found in adipose tissue, the liver and the central nervous system. It provides sufficient intracellular cortisol levels when circulating levels are low by converting inactive circulating cortisone to active cortisol. 13, 14 With increasing body mass index (BMI), 11b-HSD1 activity and expression increases in subcutaneous adipose tissue (SC) in humans. [15] [16] [17] [18] The potential importance of pre-receptor glucocorticoid metabolism in the metabolic syndrome is illustrated by transgenic mice that overexpress 11b-HSD1 in adipose tissue. These rodents have a tissue-specific increase in glucocorticoid concentrations linked to visceral obesity, insulin resistance, hyperglycemia, dyslipidemia and hypertension. 19, 20 Conversely, homozygous 11b-HSD1 'knockout' mice have an inability to interconvert inactive glucocorticoids to their active forms, which seems to protect them from features of the metabolic syndrome. 21 Several adipocytokines may also influence systemic metabolism and insulin sensitivity through endocrine, paracrine or autocrine pathways. In experimental models and obese humans, alterations in the secretion of leptin and adiponectin in adipose tissue results in metabolic dysfunctions. 22, 23 A relationship between tumor necrosis factor alpha (TNFa) and resistin expression levels in adipose tissue and insulin resistance has also been proposed. 24, 25 However, these latter data are contradictory and the release of TNFa and resistin by adipose tissue of obese humans is primarily owing to non-fat cells present in the tissue, for example, monocytes and macrophages. 26, 27 Studies on adults have shown that expression of the genes encoding leptin, adiponectin and interleukin 6 differ between SC and omental adipose tissue (OM), [28] [29] [30] [31] and glucocorticoids may influence the expression of these genes. [31] [32] [33] Early alterations (i.e. during childhood) in the activity of 11b-HSD1 and in the secretion of specific adipocytokines may play a key role in the development of obesity-related complications with increasing age. We investigated messenger RNA (mRNA) expression of 11b-HSD1, and the adipocytokines leptin, TNFa and resistin in paired samples of SC and OM and evaluated putative associations between expression levels and age, sex and anthropometrical measures.
Subjects and methods
Subjects and sample acquisition Experimental protocols were approved by the Ethical Committees of the Faculties of Medicine, Umeå University Sweden and Nanjing Medical University, China. Before they were included in this study, the participants or their parents gave their informed consent.
Abdominal SC and OM biopsies were obtained from 54 children and 16 adults undergoing open abdominal surgery.
Of the children, eighteen had reconstructive surgery owing to various malformations of the digestive tract, (nine Hirschprunǵs disease, four gastric-oesophageal reflux, three malrotation, two choledochocele), nine were operated on owing to intussusception, and five owing to mesenteric cysts. Seventeen were operated on the suspicion of appendicitis (12 confirmed), and five operations were owing to benign diseases (four gastrostomy owing to feeding problems and one laparoscopy). Of the 16 adults, five women had surgery for non-malignant gynecological diseases, four underwent gastric surgery owing to gastric hernia and gastritis, and seven underwent cholecystectomy (four cholecystolithiasis, two cholecystitis and one choledochocele). None of the individuals had diabetes, a family history of diabetes or suffered from thyroid dysfunction or severe systemic illness.
Anthropometrical measurements were carried out before surgery. BMI was calculated as weight (kg) divided by height squared (m 2 ). For children, BMI values were transformed to BMI standard deviation score (SDS). 34, 35 Use of BMI SDS corrects for variation with age and gender in children and allows pooling of data. Overweight and obesity were classified according to the IASO international obesity task force (IOTF) criteria. 35 These BMI cutoffs were derived from sex-specific BMI age curves that pass through a BMI of 25 and 30 kg/m 2 at 18 years of age, respectively (the cutoff points used to define overweight and obesity in adults). For the age group below 2 years of age, overweight and obesity were classified according to de Onis and Blossner. 36 Using these criteria, 13 out of the 54 children and seven out of the 16 adults were overweight or obese. Owing to the limited sample size in this study, overweight and obese subjects were grouped together in the analyses and referred to as overweight. Waist circumference was measured at the umbilicus level. The hip circumference was measured to yield the maximum circumference over the buttocks (upright position from 3 years of age). Waist-hip ratio was calculated by dividing waist circumference by hip circumference. All patients had fasted for at least 8 h before surgery, and underwent general anesthesia. Visible blood vessels and blood clots were removed from the collected adipose tissue and the tissue immediately frozen in liquid nitrogen and stored at À701C until analysis.
RNA preparation
Total RNA was isolated from cells or tissues using TRIZOL Reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. The integrity of the RNA was verified by ethidium bromide staining of ribosomal RNA bands separated on a 1% agarose gel. The RNA was stored at À701C until use.
mRNA quantification
Quantitative real-time polymerase chain reaction (PCR) was used to determine relative mRNA levels. First, complemen11b-HSD1 and leptin in adipose tissue of children X Li et al tary DNA was synthesized from 1 mg of total RNA using random hexamers and TaqMan Reverse Transcription Reagents (Applied Biosystems, Foster City, CA, USA). Sequencespecific primers and probes for 11b-HSD1, leptin, TNFa and resistin (Table 1) were designed according to guidelines for quantitative TaqMan real-time PCR using Primer Express 1.0 software (Applied Biosystems). The probes were labelled at the 5 0 -end with the reporter dye 6-carboxy-fluorescein and at 3 0 -end with the quencher 6-carboxy-tetramethyl-rhodamine. All real-time PCR reactions were carried out using the TaqMan Universal PCR Master Mix according to the manufacturer's protocol (Applied Biosystems). The samples were run in triplicate on an ABI Prism 7000 sequence detection system (Applied Biosystems) using the following cycling parameters: 501C for 2 min and 951C for 10 min, followed by 40 cycles at 951C for 15 s and 601C for 1 min.
To obtain standard curves, we used RNA isolated from different, appropriate sources, that is, cells or tissues expressing relatively high levels of the mRNA of interest: blood lymphocytes for TNFa, blood mononuclear cells for resistin and human adipose tissue for 11b-HSD1 and leptin standards, respectively.
To identify the best endogenous control to use as internal standard, we analyzed mRNA isolated from four different samples of adipose tissue (SC and OM) using the Human Endogenous Control Assay (Applied Biosystems). Among 11 different RNAs tested, b-actin varied the least between samples and was therefore measured as an endogenous internal control in all samples. The mRNA values obtained for 11b-HSD1, leptin, TNFa and resistin were calculated relative to b-actin. Primers and probe used to measure b-actin mRNA levels were from Applied Biosystems.
Statistical analysis
All calculations were made with the Statistical Package for Social Sciences (version 12.0 from SPSS Inc., Chicago, IL, USA). As part of the data was skewly distributed, they are presented as medians (range) in the text and in Table 2 , and in the figures as medians and quartiles. Putative differences 
Abbreviations: HSD, hydroxysteroid dehydrogenase; TNF, tumor necrosis factor. 11b-HSD1 and leptin in adipose tissue of children X Li et al in mRNA levels between SC and OM were assessed by the Wilcoxon-signed ranks test. The differences between normal weight and overweight children were assessed by the MannWhitney U-test. In the correlation analyses, the data were log-transformed if their distribution was skewed, and the relationships among variables were calculated by the Pearson's correlation or partial correlation test. Variables that correlated significantly to gene expression were included in separate multiple regression analyses. Significance was assigned to P-values o0.05.
Results

Differences in gene expression between SC and OM
The clinical characteristics of the subjects are summarized in Table 2 .
For both children and adults, the median 11b-HSD1 mRNA levels were slightly higher in OM compared to SC: 0.16 vs 0.13 for children and 0.18 vs 0.09 for adults (relative values) (Figure 1a ). The median leptin mRNA level was consistently higher in SC compared to OM: 0.57 vs 0.08 in children and 1.08 vs 0.53 in adults (relative values) (Figure 1b) . When normal weight and overweight children were analyzed separately, the depot-specific differences remained for leptin, whereas for 11b-HSD1 the depot-specific differences remained only for normal weight children (Figure 2 ). The mRNA levels of both 11b-HSD1 and leptin in SC were higher in overweight compared to normal weight children (P ¼ 0.012 and Po0.001, respectively). The leptin mRNA level in OM was higher in overweight compared to normal weight children (Po0.001), whereas the difference for 11b-HSD1 in OM did not reach statistical significance (P ¼ 0.235).
TNFa and resistin mRNA levels were low in most samples with no significant difference between SC and OM in children or adults. Notably, resistin mRNA was not detectable (i.e. the Ct value was above 40) in 20 out of the 70 individuals investigated (data not shown).
Associations between mRNA expression levels and age, gender and indices of overweight The 11b-HSD1 mRNA level correlated positively with age in OM, but not in SC (Figure 3 ). This association remained after adjustment for concomitant disease (data not shown). Leptin mRNA expression level did not correlate with age (data not shown). There was no association between gender and gene expression levels for 11b-HSD1 or leptin, neither in children, nor in adults (data not shown).
In children, 11b-HSD1 expression correlated positively to BMI SDS in SC but not in OM (Figure 4) , whereas leptin mRNA levels correlated positively to BMI SDS in both SC and OM ( Figure 5 ). The association between 11b-HSD1 In adults, leptin mRNA level in both depots correlated to BMI (SC: r ¼ 0.67, P ¼ 0.004; OM: r ¼ 0.64, P ¼ 0.008). None of the other mRNAs analyzed (11b-HSD1, resistin and TNFa) correlated to BMI.
Relationship between the gene expressions in SC and OM For 11b-HSD1, leptin and TNFa mRNA expression there was a significant correlation between the two sites (r ¼ 0.36, P ¼ 0.007; r ¼ 0.64, Po0.001; r ¼ 0.34, P ¼ 0.001, respectively). When normal weight and overweight children were analyzed separately, 11b-HSD1 mRNA levels were positively associated to those of leptin in OM (r ¼ 0.57, P ¼ 0.044) from the overweight group.
Discussion
To our knowledge, this is the first study of 11b-HSD1 and the adipocytokines TNFa and resistin in children that compares the expression levels in paired samples of SC and OM. The most novel finding is that the level of 11b-HSD1 mRNA was higher in OM compared to SC, particularly in normal weight subjects. Consistent with this, previous studies in cultured preadipocytes, isolated from adults, have reported a higher expression and higher enzymatic activity of 11b-HSD1 in OM as compared to SC. [37] [38] [39] However, it should be noted that data from cultured preadipocytes isolated from SC and OM differs from observations made in adipocytes and intact adipose tissue from the two sites. 38 In humans, 11b-HSD1 is expressed both in adipocytes and preadipocytes, but the expression seems to be higher in preadipocytes. A difference between sites with respect to cell density and proportions (e.g. preadipocytes) in obese individuals 40 could contribute to the variations in 11b-HSD1 expression observed between subjects studied and cultured cells. Further, the degree of 11b-HSD1 and leptin in adipose tissue of children X Li et al inflammation may also have an impact. The number of adipose tissue macrophages increases with obesity and are involved in inflammatory pathways that are activated in obese individuals. For example, adipose tissue macrophages seem to be responsible for virtually all adipose tissue TNFa expression. 41 Locally produced TNFa may further increase the production of 11b-HSD1. 42 It seems important in future studies to delineate the distribution and proportion of various cell types in adipose tissue in relation to obesity, and particularly to type of obesity, in both children and adults. 11b-HSD1 mRNA in OM adipose tissue increased with age, after controlling for BMI and gender. Accumulation of adipose tissue mass may occur by preadipocyte differentiation, by increased lipid accumulation within already differentiated cells, or by preadipocyte proliferation, thus increasing the pool of cells available for differentiation. Cortisol induces the differentiation of preadipocyte into mature adipocytes but inhibits cellular proliferation, and 11b-HSD1 has been suggested to be key in this process. 37, 38 Adipose tissue mass is limited in early life, and the mass increases mainly by preadipocyte proliferation and formation of small adipocytes, which may influence adiposity in later life. 43 Thus, increased 11b-HSD1 mRNA expression with age may reflect a causal role in adipocyte differentiation and fat accumulation, particularly of visceral fat during growth, which links to obesity and morbidity in adult life. Mice overexpressing 11bHSD1 develop profound central obesity and insulin resistance. 19 Elevated 11b-HSD1 mRNA levels and enzyme activity were reported in SC of obese, adult patients, [15] [16] [17] [18] and it has been suggested that the increased 11b-HSD1 expression in SC may participate in the metabolic disturbance induced by obesity. 44, 45 Consistent with this, we found a positive association between 11b-HSD1 in SC and BMI SDS in children. However, our data showed no significant association between 11b-HSD1 mRNA levels and BMI in either OM or SC in adults. This is most likely explained by the limited number of observations. We also found no significant association between 11b-HSD1 mRNA levels in OM and BMI or waist circumference in children. The seemingly surprising observation that in overweight children 11b-HSD1 mRNA expression was increased in SC but not in OM could be interpreted as meaning that enzyme activity in OM is not causal in the development of visceral obesity. Interestingly, several studies have shown that increased 11b-HSD1 expression in SC is related to accumulation of both subcutaneous and visceral fat, and to features of insulin resistance in obese adults, 44, 45 whereas
Tomlinson et al. 38 reported that 11b-HSD1 activity in preadipocytes is decreased in OM from obese patients and inversely correlates with BMI. As accumulation of adipose tissue mass may occur by preadipocyte differentiation, or by preadipocyte proliferation, 11b-HSD1 could act to increase adipocyte differentiation, but simultaneously inhibit preadipocyte proliferation. These findings indicate that local 11b-HSD1 activity may control development of visceral obesity in a site-specific manner. It seemed prudent in this study also to determine the mRNA expression levels for some of the adipocytokines implicated in obesity, the expression of which also is regulated by glucocorticoids. TNFa produced by adipose tissue is regarded as a possible mediator of obesity-linked insulin resistance. 24 However, studies in humans have produced controversial results. Several studies have demonstrated that TNFa mRNA levels in adipocytes are low 29, 30 and in obese individuals primarily originate from non-fat cells. 26 Thus, adipose tissues probably do not make a major contribution to circulating levels of TNFa. In agreement with these studies, we found that the expression level of TNFa in human adipose tissue was low with no depot-related difference.
Leptin is a mainly adipocyte-secreted protein that plays a major role in the control of body weight and energy homeostasis. In obese adults, leptin is linked to insulin resistance and predicts cardiovascular disease. 46, 47 We confirmed differences in leptin mRNA expression between SC and OM in children 48 and adults, 30 and the association between leptin and BMI, thus extending earlier studies to children. Moreover, our studies showed an association between leptin mRNA expression and waist or hip circumferences in SC and OM. Further studies are needed to 11b-HSD1 and leptin in adipose tissue of children X Li et al evaluate leptin as a marker/predictor of obesity-related complications in children.
Notably, glucocorticoids may regulate leptin in adipose tissue. Synthesis and secretion of leptin from human adipose tissue is increased by exogenously administered glucocorticoids in vitro, and this effect is more evident in OM than in SC. 32 Importantly, adipose tissue-specific transgenic overexpression of 11b-HSD1 in mice leads to a substantial increase in serum leptin concentrations. 19 Similarly, our results showed that the leptin mRNA level in OM was positively associated to 11b-HSD1 in overweight children.
Resistin has been proposed as a link obesity to insulin resistance, as resistin levels are increased in obesity. 25 Resistin transcripts are found in adipose tissue of obese individuals but there is no correlation between resistin mRNA and BMI or insulin resistance. 27, 49, 50 Moreover, resistin is expressed in the stromavascular fraction of adipose tissue and in peripheral blood monocytes, but its mRNA is not detectable in human adipocytes even in obese individuals. 27, 49 We found that resistin mRNA levels were generally low, both in children and adults, and in fact were not even detectable in a considerable proportion of the children. Recent reports of the relation of resistin expression and obesity or insulin resistance in mice may not readily translate to humans. 49, 50 Thus, the function of resistin in humans remains to be established. It should be noted that as the mass of adipose tissue is limited in young children, and the amount that could be taken for analysis was small, this study focused only on mRNA levels in adipose tissue, that is, the small sample size did not allow us to do a complementary protein quantification to confirm our mRNA results. However, we have previously shown good agreement between mRNA expression and 11b-HSD1 enzyme activity in SC in adults. 17 Our results cannot totally exclude a discrepancy between 11b-HSD1 mRNA expression and protein level in OM in children, nor for the other adipocytokines studied. The fact that the material was heterogeneous with respect to age and diagnoses may have confounded the study. This was unavoidable both for ethical reasons and owing to the design of the study. All patients were subjected to open surgery for a reason (diagnosis), and samples for the study were collected during the operation. However, there was no statistical difference in gene expression levels between the children with appendicitis (inflammation) and the remaining group of children. This does not completely rule out that any of the other diagnoses could have affected the results, although they were less likely to do so. Moreover, the other diagnoses groups were all too small to allow separate analysis.
11b-HSD1 activity (assessed by urinary metabolites) has previously been shown to decrease in girls during puberty. 51 In the present study, we compared 11b-HSD1 and leptin expression levels in SC and OM between female and male subjects both in children and adults and did not find any significant differences between genders. There was no significant change in 11b-HSD1 expression with age (o6 years of age vs X6 years of age), when girls and boys were analyzed separately. However, we cannot completely rule out that this lack of difference may partly result from the comparatively small sample size, in particular of pubertal girls as only four girls were older than 6 years of age. It should also be noted that within the group of children there were twice as many male as female subjects, whereas within the group of adults the distribution was the opposite. Larger studies, particularly on obese children and adolescences, are needed to extend the significance of our observations with respect to development of obesity and/or obesity-related metabolic complication in children.
In conclusion, depot-specific differences in mRNA levels of 11b-HSD1 and leptin were present in childhood. 11b-HSD1 in OM increased with age whereas 11b-HSD1 and leptin in SC were positively associated with BMI SDS. Moreover, 11b-HSD1 was significantly associated to leptin in OM among overweight children. 11b-HSD1 activity, by influencing local glucocorticoid tissue exposure, may play an important role in visceral fat accumulation during growth. Increasing 11b-HSD1 and leptin mRNA in SC with increasing BMI SDS may suggest that the risk of the metabolic consequences of obesity may be established at an early stage in life.
